Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results o...

por Schlesinger, Naomi, De Meulemeester, Marc, Pikhlak, Andrey, Yücel, A Eftal, Richard, Dominik, Murphy, Valda, Arulmani, Udayasankar, Sallstig, Peter, So, Alexander
Publicado 2011

Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03(A)-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial

por Heijmans, Stéphane, De Meulemeester, Marc, Reynders, Paul, Giet, Didier, Demanet, Etienne, Devresse, Pierre-Yves, Icardi, Giancarlo, Dramé, Mamadou, Roman, François, Gillard, Paul
Publicado 2011

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

por Schlesinger, Naomi, Mysler, Eduardo, Lin, Hsiao-Yi, De Meulemeester, Marc, Rovensky, Jozef, Arulmani, Udayasankar, Balfour, Alison, Krammer, Gerhard, Sallstig, Peter, So, Alexander
Publicado 2011

Understanding the patient voice in gout: a quantitative study conducted in Europe

por De Meulemeester, Marc, Mateus, Elsa, Wieberneit-Tolman, Hilda, Betteridge, Neil, Ireland, Lucy, Petersen, Gudula, Maske, Nina Jeanette, Jansen, Tim L, Perez-Ruiz, Fernando
Publicado 2020